"میتھامفیتامین" کے نسخوں کے درمیان فرق

حذف شدہ مندرجات اضافہ شدہ مندرجات
1 مآخذ کو بحال کرکے 0 پر مردہ ربط کا ٹیگ لگایا گیا) #IABot (v2.0.7
سطر 25:
| legal_DE = Anlage II
| licence_US = Methamphetamine
| routes_of_administration= Medical: [[Oral route|oral (ingestion)]]، [[intravenous administration|intravenous]]<ref name="RxMethIV">{{Cite book|title = Amphetamine legislation 1971: Hearings, Ninety-second Congress, first session, pursuant to S. Res. 32, section 12, investigation of juvenile delinquency in the United States|url = https://bulk.resource.org/gao.gov/91-513/000050D8.pdf|publisher = U.S. Govt. Print. Off.|date = 1 جنوری 1972|last = United States Congress Senate Committee on the Judiciary Subcommittee to Investigate Juvenile Delinquincy|quote = We made a decision in جنوری of 1969 to cease the manufacture of injectable methamphetamines.|page = 161|access-date = 1 جنوری 2016|archive-date = 2010-05-06|archive-url = https://web.archive.org/web/20100506193205/http://bulk.resource.org/gao.gov/91-513/000050D8.pdf|url-status = dead}}</ref><br/>Recreational: [[Oral route|oral]]، [[intravenous administration|intravenous]]، [[intramuscular administration|intramuscular]]، [[subcutaneous administration|subcutaneous]]، [[smoking|smoke inhalation]]، [[Insufflation (medicine)|insufflation]]، [[شافہ]]، [[intravaginal administration|vaginal]]
<!-- Pharmacokinetic data -->
| bioavailability= Oral: 70%<ref name="Bioavailability">{{cite journal | vauthors = Rau T, Ziemniak J, Poulsen D | title = The neuroprotective potential of low-dose methamphetamine in preclinical models of stroke and traumatic brain injury | journal = Prog. Neuropsychopharmacol. Biol. Psychiatry | volume = 64| issue = | pages = 231–6| year = 2015 | pmid = 25724762 | doi = 10.1016/j.pnpbp.2015.02.013 | quote = In humans, the oral bioavailability of methamphetamine is approximately 70% but increases to 100% following intravenous (IV) delivery (Ares-Santos et al.، 2013)۔}}</ref><br/>IV: 100%<ref name="Bioavailability"/>